Medication for Motion Sickness
For motion sickness prevention, use scopolamine (transdermal patch) as first-line therapy, or alternatively first-generation antihistamines like meclizine or dimenhydrinate; ondansetron and non-sedating antihistamines are NOT effective for motion sickness. 1, 2, 3
First-Line Medications
Scopolamine (Hyoscine)
- Most effective prophylactic agent based on multiple RCTs 2, 3
- Transdermal patch: Apply several hours (ideally 4-6 hours) before anticipated motion exposure
- Adult dosing: 1.5 mg patch applied behind ear, effective for up to 72 hours
- Mechanism: Anticholinergic that blocks acetylcholine in the CNS, reducing neural mismatch 4
- Common side effect: Dry mouth (more common than with other agents) 3
- Other side effects: Drowsiness, blurred vision, dizziness (though not significantly more than other agents in trials) 3
First-Generation Antihistamines (Alternative First-Line)
These are effective alternatives when scopolamine is contraindicated or unavailable 1, 5:
Meclizine
- Adult dosing: 25-50 mg orally, taken 1 hour before travel
- Pediatric dosing: Reported effective in children, though specific dosing requires consultation with pediatric formularies 6
- Duration: 12-24 hours
Dimenhydrinate
- Adult dosing: 50-100 mg every 4-6 hours (max 400 mg/day)
- Pediatric dosing:
- Ages 2-6 years: 12.5-25 mg every 6-8 hours (max 75 mg/day)
- Ages 6-12 years: 25-50 mg every 6-8 hours (max 150 mg/day)
Diphenhydramine
- Adult dosing: 25-50 mg every 4-6 hours
- Pediatric dosing: 1-2 mg/kg per dose 7, 4
- Mechanism: Suppressive effect on central emetic center 4
Medications That Do NOT Work
Avoid these for motion sickness 1:
- Ondansetron: Despite being effective for chemotherapy-induced nausea, it is NOT effective for motion sickness
- Non-sedating antihistamines (e.g., loratadine, cetirizine): Ineffective
- Ginger root: Not effective based on evidence
Pediatric Considerations
Special populations where motion sickness occurs 6:
- Can affect even infants and toddlers (onset as early as 0-15 years, mean 6.6 years)
- Common comorbidities: migraine variants (47.8%), vestibular deficits (23.5%), recurrent otitis media (39.1%), motor delay (30.4%)
Pediatric treatment options with reported success 6:
- Meclizine: High proportion showed improvement
- Ondansetron: Reported helpful in pediatric case series (contradicts adult data—may reflect different pathophysiology or placebo effect)
- Cyproheptadine: Antihistamine with antiserotonergic properties, showed improvement
- Vestibular rehabilitation: Non-pharmacologic option
Contraindications and Precautions
Scopolamine contraindications:
- Narrow-angle glaucoma
- Urinary retention
- Severe ulcerative colitis
- Myasthenia gravis
- Pregnancy category C
Antihistamine precautions:
- Sedation (avoid driving/operating machinery)
- Anticholinergic effects (dry mouth, urinary retention, constipation)
- Caution in elderly (increased fall risk, confusion)
Clinical Pitfalls to Avoid
Timing is critical: All medications work best as prophylaxis, NOT treatment of established symptoms 2, 3. No RCTs demonstrate effectiveness once symptoms are established.
Don't prescribe ondansetron: Despite its widespread use for nausea/vomiting in other contexts, it lacks efficacy for motion sickness 1
Vestibular suppressants are NOT for BPPV: While antihistamines help motion sickness, they should NOT be routinely used for benign paroxysmal positional vertigo (different pathophysiology) 4
Sedation is part of efficacy: The sedating properties of first-generation antihistamines may contribute to their effectiveness; non-sedating alternatives don't work 1
Treatment Algorithm
Step 1: Behavioral modifications first (position in stable part of vehicle, watch horizon, avoid reading, adequate ventilation)
Step 2: If behavioral measures insufficient:
- Preferred: Scopolamine transdermal patch applied 4-6 hours before travel
- Alternative: First-generation antihistamine (meclizine 25-50 mg or dimenhydrinate 50-100 mg) 1 hour before travel
Step 3: For refractory cases: